ProShare Advisors
SRPT icon

ProShare Advisors’s Sarepta Therapeutics SRPT Stock Holding History

Quarter Market Value Status Shares Shares
Change %
Trade Value Portfolio Weight Portfolio Position
2025
Q2
Sell
-8,447
Closed -$539K 2177
2025
Q1
$539K Sell
8,447
-547
-6% -$34.9K ﹤0.01% 1051
2024
Q4
$1.09M Sell
8,994
-799
-8% -$97.2K ﹤0.01% 874
2024
Q3
$1.22M Sell
9,793
-493
-5% -$61.6K ﹤0.01% 761
2024
Q2
$1.63M Buy
10,286
+3,708
+56% +$586K ﹤0.01% 691
2024
Q1
$852K Buy
6,578
+601
+10% +$77.8K ﹤0.01% 838
2023
Q4
$576K Sell
5,977
-121
-2% -$11.7K ﹤0.01% 963
2023
Q3
$739K Buy
6,098
+71
+1% +$8.61K ﹤0.01% 781
2023
Q2
$690K Sell
6,027
-73
-1% -$8.36K ﹤0.01% 817
2023
Q1
$841K Sell
6,100
-2,491
-29% -$343K ﹤0.01% 754
2022
Q4
$1.11M Sell
8,591
-170
-2% -$22K ﹤0.01% 719
2022
Q3
$968K Buy
8,761
+512
+6% +$56.6K ﹤0.01% 739
2022
Q2
$618K Sell
8,249
-2,753
-25% -$206K ﹤0.01% 876
2022
Q1
$859K Sell
11,002
-3,448
-24% -$269K ﹤0.01% 979
2021
Q4
$1.3M Sell
14,450
-4,502
-24% -$405K ﹤0.01% 905
2021
Q3
$1.75M Buy
18,952
+1,734
+10% +$160K ﹤0.01% 749
2021
Q2
$1.34M Buy
17,218
+4,807
+39% +$374K ﹤0.01% 878
2021
Q1
$925K Sell
12,411
-1,189
-9% -$88.6K ﹤0.01% 1039
2020
Q4
$2.32M Sell
13,600
-409
-3% -$69.7K 0.01% 596
2020
Q3
$1.97M Buy
14,009
+352
+3% +$49.4K 0.01% 574
2020
Q2
$2.19M Buy
13,657
+2,099
+18% +$337K 0.01% 544
2020
Q1
$1.13M Sell
11,558
-6,254
-35% -$612K 0.01% 576
2019
Q4
$2.3M Sell
17,812
-3,973
-18% -$513K 0.01% 588
2019
Q3
$1.64M Sell
21,785
-1,569
-7% -$118K 0.01% 631
2019
Q2
$3.55M Sell
23,354
-3,529
-13% -$536K 0.02% 475
2019
Q1
$3.2M Buy
26,883
+1,033
+4% +$123K 0.02% 499
2018
Q4
$2.82M Sell
25,850
-3,451
-12% -$377K 0.02% 501
2018
Q3
$4.73M Buy
29,301
+1,763
+6% +$285K 0.03% 431
2018
Q2
$3.64M Sell
27,538
-10,158
-27% -$1.34M 0.02% 505
2018
Q1
$2.79M Sell
37,696
-6,198
-14% -$459K 0.02% 551
2017
Q4
$2.44M Buy
43,894
+3,592
+9% +$200K 0.02% 564
2017
Q3
$1.83M Buy
40,302
+7,503
+23% +$340K 0.02% 579
2017
Q2
$1.11M Sell
32,799
-2,227
-6% -$75.1K 0.01% 707
2017
Q1
$1.04M Sell
35,026
-9,093
-21% -$269K 0.01% 736
2016
Q4
$1.21M Buy
44,119
+9,080
+26% +$249K 0.01% 695
2016
Q3
$2.15M Sell
35,039
-4,257
-11% -$261K 0.03% 466
2016
Q2
$749K Buy
39,296
+10
+0% +$191 0.01% 807
2016
Q1
$767K Sell
39,286
-3,636
-8% -$71K 0.01% 820
2015
Q4
$1.66M Buy
42,922
+7,301
+20% +$282K 0.02% 568
2015
Q3
$1.14M Sell
35,621
-2,743
-7% -$88.1K 0.02% 637
2015
Q2
$1.17M Sell
38,364
-2,781
-7% -$84.6K 0.02% 708
2015
Q1
$546K Buy
41,145
+5,052
+14% +$67K 0.01% 1133
2014
Q4
$522K Sell
36,093
-1,152
-3% -$16.7K 0.01% 1177
2014
Q3
$786K Sell
37,245
-7,274
-16% -$154K 0.01% 1162
2014
Q2
$1.33M Sell
44,519
-22,315
-33% -$665K 0.02% 1032
2014
Q1
$1.61M Buy
66,834
+47,542
+246% +$1.14M 0.02% 909
2013
Q4
$393K Sell
19,292
-13,663
-41% -$278K 0.01% 1101
2013
Q3
$1.56M Buy
32,955
+26,874
+442% +$1.27M 0.04% 549
2013
Q2
$231K Buy
+6,081
New +$231K ﹤0.01% 1921